Business Description
Achieve Life Sciences Inc
NAICS : 325413
SIC : 2835
ISIN : US0044682039
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.86 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | -0.72 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 36.7 | |||||
3-Year EPS without NRI Growth Rate | 35.2 | |||||
3-Year FCF Growth Rate | 37.1 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.57 | |||||
9-Day RSI | 60.96 | |||||
14-Day RSI | 59.05 | |||||
6-1 Month Momentum % | -3.17 | |||||
12-1 Month Momentum % | -47.07 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.29 | |||||
Quick Ratio | 3.29 | |||||
Cash Ratio | 3.23 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -51.3 | |||||
Shareholder Yield % | -41.81 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -219.63 | |||||
ROA % | -83.56 | |||||
ROIC % | -174.38 | |||||
ROC (Joel Greenblatt) % | -30204.49 | |||||
ROCE % | -128.53 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.47 | |||||
Price-to-Tangible-Book | 3.72 | |||||
EV-to-EBIT | -5.07 | |||||
EV-to-EBITDA | -5.12 | |||||
EV-to-FCF | -5.72 | |||||
Price-to-Net-Current-Asset-Value | 3.72 | |||||
Price-to-Net-Cash | 3.85 | |||||
Earnings Yield (Greenblatt) % | -19.72 | |||||
FCF Yield % | -12.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Achieve Life Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -1.175 | ||
Beta | 1.86 | ||
Volatility % | 72.66 | ||
14-Day RSI | 59.05 | ||
14-Day ATR (€) | 0.093059 | ||
20-Day SMA (€) | 4.18 | ||
12-1 Month Momentum % | -47.07 | ||
52-Week Range (€) | 2.84 - 7.2 | ||
Shares Outstanding (Mil) | 34.34 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Achieve Life Sciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Achieve Life Sciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Achieve Life Sciences Inc Frequently Asked Questions
What is Achieve Life Sciences Inc(FRA:SP4P)'s stock price today?
When is next earnings date of Achieve Life Sciences Inc(FRA:SP4P)?
Does Achieve Life Sciences Inc(FRA:SP4P) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |